Recombinant SARS-CoV-2 Spike protein S1 subunit, encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.1.529 BA.1, also known as variant Omicron BA.1 originally identified in South Africa, and contains genetic alterations indicated below. It was constructed with a C-terminal Avi-Tag followed by a His-tag (6xHis). The protein was enzymatically biotinylated using the Avi-Tag and affinity purified. Constructs: Spike S1 (B.1.1.529 BA.1 Variant) (16-685-Avi-His) - (Biotin) (SARS-CoV-2)
Immunogen Region
16-685
Tag
C-terminal Avi-His-tag
Formulation
8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol
Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling
Notes
Assay run according to the Spike S1 (B.1.1.529 BA.1, Omicron Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit (Biohippo #78358). 5 ng of ACE2-Eu, 400-fold diluted Dye-labeled acceptor, and various amounts of Spike S1(B) incubated for 1 hour at room temperature. TR-FRET measured at ex340 ± 20nm, em620 ± 10 nm; and ex340 ± 20nm, em665 ± 10 nm.